Phase 3 VALIANT

HOUSTON, Texas | April 10, 2026 FibroBiologics has unveiled promising preclinical data for its novel thymus organoid platform, demonstrating...

WALTHAM, Massachusetts | April 9, 2026 Swedish Orphan Biovitrum (Sobi) has announced that Health Canada has approved EMPAVELI® (pegcetacoplan),...